Trupanion, Inc. (NASDAQ:TRUP) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,745 shares of the financial services provider’s stock after buying an additional 717 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Trupanion were worth $904,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new position in Trupanion during the fourth quarter worth about $25,000. Jones Financial Companies Lllp lifted its stake in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Quarry LP acquired a new position in shares of Trupanion during the 4th quarter worth approximately $39,000. Aster Capital Management DIFC Ltd boosted its holdings in shares of Trupanion by 988.5% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 1,028 shares during the last quarter. Finally, Coppell Advisory Solutions LLC grew its position in shares of Trupanion by 58.3% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 460 shares in the last quarter.

Trupanion Stock Up 0.8%

Shares of NASDAQ:TRUP opened at $44.54 on Tuesday. The company has a market capitalization of $1.91 billion, a price-to-earnings ratio of -193.65, a PEG ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The business has a 50-day moving average price of $39.09 and a 200 day moving average price of $43.94. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The business had revenue of $341.98 million during the quarter, compared to analysts’ expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business’s revenue for the quarter was up 11.7% on a year-over-year basis. During the same period last year, the business earned ($0.16) earnings per share. Sell-side analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Activity

In related news, SVP Emily Dreyer sold 14,025 shares of Trupanion stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now directly owns 27,645 shares in the company, valued at approximately $895,974.45. This trade represents a 33.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the transaction, the chief financial officer now owns 2,416 shares of the company’s stock, valued at $82,675.52. The trade was a 36.24% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 37,792 shares of company stock valued at $1,306,242. 5.42% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

TRUP has been the topic of several analyst reports. Lake Street Capital reduced their price target on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, May 2nd. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Finally, Piper Sandler decreased their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $51.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.